SCHEMBL30838260

SCHEMBL30838260

CC(C)CNCc1cc(C(=O)Nc2cccc(C3(c4nncn4C)CC4(CC(C)C4)C3)c2)c(=O)n(CC(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 20/20 0.44
▸ CBL P22681 17/20 0.41
▸ CBLC Q9ULV8 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30838216 0.95 CBLB (0.49) CBLBCBLCBLC
SCHEMBL30838130 0.94 CBLB (0.39) CBLBCBLCBLC
SCHEMBL30838322 0.92 CBLB (0.39) CBLBCBLCBLC
SCHEMBL30838155 0.92 CBLB (0.40) CBLBCBLCBLC
SCHEMBL30838362 0.92 CBLB (0.39) CBLBCBLCBLC
SCHEMBL30838350 0.89 CBLB (0.36) CBLBCBLCBLC
SCHEMBL27364738 0.89 CBLB (0.47) CBLBCBLCBLC
SCHEMBL30838301 0.89 CBLB (0.47) CBLBCBLCBLC
SCHEMBL30838348 0.89 CBLB (0.48) CBLBCBLCBLC
SCHEMBL30838381 0.89 CBLB (0.48) CBLBCBLCBLC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4573085-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS Glenmark Pharmaceuticals Limited (IN) 2025-06-25 — — EP claimed
WO-2024038378-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2024-02-22 — — WO claimed
Send feedback